Which has higher earnings & valuation, MEDP or SHC?

Medpace has higher revenue and earnings than Sotera Health. Medpace is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medpace $2.53B 6.52 $451.12M $17.06 34.62 Sotera Health $1.16B 4.62 $77.94M $0.41 46.00

Is MEDP or SHC more profitable?

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity. Company Net Margins Return on Equity Return on Assets Medpace 17.67% 110.15% 24.84% Sotera Health 13.44% 40.12% 7.55%

Does the media prefer MEDP or SHC?

In the previous week, Sotera Health had 9 more articles in the media than Medpace. MarketBeat recorded 18 mentions for Sotera Health and 9 mentions for Medpace. Medpace's average media sentiment score of 1.25 beat Sotera Health's score of 0.89 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 7 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 7 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, SHC or RVTY?

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 4.62 $77.94M $0.41 46.00 Revvity $2.86B 4.48 $241.20M $2.10 54.67

Is SHC or RVTY more profitable?

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 13.44% 40.12% 7.55% Revvity 8.16% 8.34% 5.01%

Does the media favor SHC or RVTY?

In the previous week, Revvity had 3 more articles in the media than Sotera Health. MarketBeat recorded 21 mentions for Revvity and 18 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.89 beat Revvity's score of 0.85 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 7 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Revvity 7 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, SHC or ICLR?

Icon has higher revenue and earnings than Sotera Health. Icon is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 4.62 $77.94M $0.41 46.00 Icon $8.25B 1.53 $229.34M $4.26 38.62

Is SHC or ICLR more profitable?

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 13.44% 40.12% 7.55% Icon 3.99% 8.02% 4.56%

Does the media favor SHC or ICLR?

In the previous week, Sotera Health had 7 more articles in the media than Icon. MarketBeat recorded 18 mentions for Sotera Health and 11 mentions for Icon. Icon's average media sentiment score of 1.05 beat Sotera Health's score of 0.89 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 7 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 7 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is TECH or SHC more profitable?

Sotera Health has a net margin of 13.44% compared to Bio-Techne's net margin of 9.05%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity. Company Net Margins Return on Equity Return on Assets Bio-Techne 9.05% 13.57% 10.66% Sotera Health 13.44% 40.12% 7.55%

Does the media refer more to TECH or SHC?

In the previous week, Sotera Health had 11 more articles in the media than Bio-Techne. MarketBeat recorded 18 mentions for Sotera Health and 7 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.37 beat Sotera Health's score of 0.89 indicating that Bio-Techne is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Techne 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 7 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Sotera Health (SHC) Competitors

$18.86 -0.05 (-0.26%)

Closing price 08/7/2026 04:00 PM Eastern

Extended Trading

$18.87 +0.01 (+0.05%)

As of 08/7/2026 07:34 PM Eastern

Compare

SHC vs. MEDP, RVTY, ICLR, CRL, and TECH

Should you buy Sotera Health stock or one of its competitors? MarketBeat compares Sotera Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sotera Health include Medpace (MEDP), Revvity (RVTY), Icon (ICLR), Charles River Laboratories International (CRL), and Bio-Techne (TECH). These companies are all part of the "life sciences tools & services" industry.

How does Sotera Health compare to Medpace?

Medpace (NASDAQ:MEDP) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Medpace currently has a consensus price target of $584.18, indicating a potential downside of 1.10%. Sotera Health has a consensus price target of $21.50, indicating a potential upside of 14.00%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts clearly believe Sotera Health is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	11 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.15
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

78.0% of Medpace shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 20.5% of Medpace shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Medpace has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market.

In the previous week, Sotera Health had 9 more articles in the media than Medpace. MarketBeat recorded 18 mentions for Sotera Health and 9 mentions for Medpace. Medpace's average media sentiment score of 1.25 beat Sotera Health's score of 0.89 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Medpace has a net margin of 17.67% compared to Sotera Health's net margin of 13.44%. Medpace's return on equity of 110.15% beat Sotera Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Sotera Health	13.44%	40.12%	7.55%

Medpace has higher revenue and earnings than Sotera Health. Medpace is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.52	$451.12M	$17.06	34.62
Sotera Health	$1.16B	4.62	$77.94M	$0.41	46.00

Summary

Medpace beats Sotera Health on 10 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Revvity?

Sotera Health (NASDAQ:SHC) and Revvity (NYSE:RVTY) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, Revvity had 3 more articles in the media than Sotera Health. MarketBeat recorded 21 mentions for Revvity and 18 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.89 beat Revvity's score of 0.85 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Revvity	7 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 86.7% of Revvity shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 0.9% of Revvity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Sotera Health presently has a consensus price target of $21.50, suggesting a potential upside of 14.00%. Revvity has a consensus price target of $108.36, suggesting a potential downside of 5.61%. Given Sotera Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Sotera Health is more favorable than Revvity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Revvity	0 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.20

Sotera Health has a net margin of 13.44% compared to Revvity's net margin of 8.16%. Sotera Health's return on equity of 40.12% beat Revvity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	13.44%	40.12%	7.55%
Revvity	8.16%	8.34%	5.01%

Sotera Health has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market. Comparatively, Revvity has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

Revvity has higher revenue and earnings than Sotera Health. Sotera Health is trading at a lower price-to-earnings ratio than Revvity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.62	$77.94M	$0.41	46.00
Revvity	$2.86B	4.48	$241.20M	$2.10	54.67

Summary

Sotera Health beats Revvity on 11 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Icon?

Sotera Health (NASDAQ:SHC) and Icon (NASDAQ:ICLR) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Sotera Health currently has a consensus target price of $21.50, suggesting a potential upside of 14.00%. Icon has a consensus target price of $170.40, suggesting a potential upside of 3.58%. Given Sotera Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sotera Health is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

In the previous week, Sotera Health had 7 more articles in the media than Icon. MarketBeat recorded 18 mentions for Sotera Health and 11 mentions for Icon. Icon's average media sentiment score of 1.05 beat Sotera Health's score of 0.89 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Icon	7 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health has a beta of 1.77, suggesting that its stock price is 77% more volatile than the broader market. Comparatively, Icon has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market.

Sotera Health has a net margin of 13.44% compared to Icon's net margin of 3.99%. Sotera Health's return on equity of 40.12% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	13.44%	40.12%	7.55%
Icon	3.99%	8.02%	4.56%

Icon has higher revenue and earnings than Sotera Health. Icon is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.62	$77.94M	$0.41	46.00
Icon	$8.25B	1.53	$229.34M	$4.26	38.62

Summary

Sotera Health beats Icon on 9 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Charles River Laboratories International?

Charles River Laboratories International (NYSE:CRL) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

In the previous week, Charles River Laboratories International had 9 more articles in the media than Sotera Health. MarketBeat recorded 27 mentions for Charles River Laboratories International and 18 mentions for Sotera Health. Charles River Laboratories International's average media sentiment score of 0.96 beat Sotera Health's score of 0.89 indicating that Charles River Laboratories International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Charles River Laboratories International	14 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Charles River Laboratories International presently has a consensus target price of $246.69, suggesting a potential downside of 7.59%. Sotera Health has a consensus target price of $21.50, suggesting a potential upside of 14.00%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Charles River Laboratories International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charles River Laboratories International	1 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.69
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Charles River Laboratories International has a beta of 1.38, indicating that its stock price is 38% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market.

Sotera Health has a net margin of 13.44% compared to Charles River Laboratories International's net margin of -5.96%. Sotera Health's return on equity of 40.12% beat Charles River Laboratories International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charles River Laboratories International	-5.96%	15.75%	6.51%
Sotera Health	13.44%	40.12%	7.55%

Sotera Health has lower revenue, but higher earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charles River Laboratories International	$4.02B	3.17	-$144.34M	-$3.76	N/A
Sotera Health	$1.16B	4.62	$77.94M	$0.41	46.00

98.9% of Charles River Laboratories International shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 1.3% of Charles River Laboratories International shares are owned by company insiders. Comparatively, 15.4% of Sotera Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Sotera Health beats Charles River Laboratories International on 11 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Sotera Health has a net margin of 13.44% compared to Bio-Techne's net margin of 9.05%. Sotera Health's return on equity of 40.12% beat Bio-Techne's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	9.05%	13.57%	10.66%
Sotera Health	13.44%	40.12%	7.55%

Bio-Techne has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market.

Bio-Techne presently has a consensus price target of $68.08, indicating a potential downside of 5.83%. Sotera Health has a consensus price target of $21.50, indicating a potential upside of 14.00%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, Sotera Health had 11 more articles in the media than Bio-Techne. MarketBeat recorded 18 mentions for Sotera Health and 7 mentions for Bio-Techne. Bio-Techne's average media sentiment score of 1.37 beat Sotera Health's score of 0.89 indicating that Bio-Techne is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	7 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health has lower revenue, but higher earnings than Bio-Techne. Sotera Health is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	9.28	$73.40M	$0.69	104.77
Sotera Health	$1.16B	4.62	$77.94M	$0.41	46.00

Summary

Sotera Health beats Bio-Techne on 9 of the 16 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SHC vs. The Competition

Export

Metric	Sotera Health	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.38B	$9.57B	$7.03B	$13.02B
Dividend Yield	N/A	1.45%	2.58%	10.20%
P/E Ratio	33.09	63.07	271.36	25.19
Price / Sales	4.62	105.68	603.79	89.40
Price / Cash	14.76	26.16	71.81	50.72
Price / Book	8.09	38.45	13.25	6.22
Net Income	$77.94M	$56.66B	$3.45B	$342.66M
7 Day Performance	5.60%	5.17%	4.67%	4.41%
1 Month Performance	2.56%	0.37%	-1.28%	-1.10%
1 Year Performance	35.00%	22.07%	77.33%	23.99%

Sotera Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SHC Sotera Health	4.0588 of 5 stars	$18.86 -0.3%	$21.50 +14.0%	+35.0%	$5.38B	$1.16B	33.09	3,000	Trending News Earnings Report Analyst Forecast
MEDP Medpace	2.6693 of 5 stars	$574.80 +0.3%	$584.18 +1.6%	+36.0%	$16.05B	$2.53B	33.70	6,200	Positive News
RVTY Revvity	2.828 of 5 stars	$110.20 -4.4%	$108.36 -1.7%	+32.0%	$12.29B	$2.86B	52.73	11,000	Earnings Report Dividend Announcement Analyst Upgrade
ICLR Icon	3.2158 of 5 stars	$156.81 -1.0%	$170.40 +8.7%	+3.8%	$12.03B	$8.25B	36.87	40,100
CRL Charles River Laboratories International	2.8162 of 5 stars	$234.56 +1.6%	$220.75 -5.9%	+79.1%	$11.30B	$4.02B	N/A	19,700	News Coverage Earnings Report Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SHC) was last updated on 8/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sotera Health (SHC) Competitors

SHC vs. MEDP, RVTY, ICLR, CRL, and TECH

How does Sotera Health compare to Medpace?

Summary

How does Sotera Health compare to Revvity?

Summary

How does Sotera Health compare to Icon?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Summary

How does Sotera Health compare to Bio-Techne?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sotera Health (SHC) Competitors

SHC vs. MEDP, RVTY, ICLR, CRL, and TECH

How does Sotera Health compare to Medpace?

Do analysts recommend MEDP or SHC?

Do institutionals & insiders believe in MEDP or SHC?

Which has more risk and volatility, MEDP or SHC?

Does the media prefer MEDP or SHC?

Is MEDP or SHC more profitable?

Which has higher earnings & valuation, MEDP or SHC?

Summary

How does Sotera Health compare to Revvity?

Does the media favor SHC or RVTY?

Do institutionals and insiders have more ownership in SHC or RVTY?

Do analysts prefer SHC or RVTY?

Is SHC or RVTY more profitable?

Which has more risk & volatility, SHC or RVTY?

Which has stronger earnings & valuation, SHC or RVTY?

Summary

How does Sotera Health compare to Icon?

Do insiders and institutionals have more ownership in SHC or ICLR?

Do analysts prefer SHC or ICLR?

Does the media favor SHC or ICLR?

Which has more risk and volatility, SHC or ICLR?

Is SHC or ICLR more profitable?

Which has better valuation & earnings, SHC or ICLR?

Summary

How does Sotera Health compare to Charles River Laboratories International?

Does the media prefer CRL or SHC?

Do analysts prefer CRL or SHC?

Which has more volatility & risk, CRL or SHC?

Is CRL or SHC more profitable?

Which has better valuation and earnings, CRL or SHC?

Do insiders and institutionals have more ownership in CRL or SHC?

Summary

How does Sotera Health compare to Bio-Techne?

Do insiders & institutionals believe in TECH or SHC?

Is TECH or SHC more profitable?

Which has more risk & volatility, TECH or SHC?

Do analysts recommend TECH or SHC?

Does the media refer more to TECH or SHC?

Which has better earnings and valuation, TECH or SHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SHC vs. The Competition

Sotera Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools